Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 12, Number 19, 2006

Articles

Favourites:
ADD

Therapeutic Modulation of Cytokines in Chronic Infectious Diseases
pp. 2329-2348(20)
Authors: Villar, C. C.; Dongari-Bagtzoglou, A.

Favourites:
ADD
Favourites:
ADD

Toll-Like Receptors, Cytokines and the Immunotherapeutics of Asthma
pp. 2365-2374(10)
Authors: Camateros, P.; Moisan, J.; Henault, J.; De Sanctis, J.; Skamene, E.; Radzioch, D.

Favourites:
ADD

Roles of Prostanoids in Colon Carcinogenesis and their Potential Targeting for Cancer Chemoprevention
pp. 2375-2382(8)
Authors: Mutoh, Michihiro; Takahashi, Mami; Wakabayashi, Keiji

Favourites:
ADD

New Frontiers in the Therapeutic Management of Transplant Rejection
pp. 2383-2395(13)
Authors: De Sanctis, Juan B.; Garmendia, Jenny V.; Radzioch, Anna; Radzioch, Danuta

Favourites:
ADD
Favourites:
ADD

Slow-Onset Inhibition of 2-trans-Enoyl-ACP (CoA) Reductase from Mycobacterium tuberculosis by an Inorganic Complex
pp. 2409-2424(16)
Authors: Oliveira, Jaim S.; de Sousa, Eduardo H.S.; de Souza, Osmar N.; Moreira, lcaro S.; Santos, Diogenes S.; Basso, Luiz A.

Favourites:
ADD

Pharmacogenetics of Antithrombotic Drugs
pp. 2425-2435(11)
Author: Tassies, D.

Favourites:
ADD

Novel Targets for Antiinflammatory and Antiarthritic Agents
pp. 2437-2454(18)
Authors: Kulkarni, R. G.; Achaiah, G.; Narahari Sastry, G.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content